HomeNewsBusinessMarketsTrade Spotlight | How you should trade in DCM Shriram, ICICI Securities, Natco Pharma

Trade Spotlight | How you should trade in DCM Shriram, ICICI Securities, Natco Pharma

Natco Pharma has seen a big breakout of around six-week consolidation with strong volumes. The stock has also seen a crossover with 50-day EMA crossing the 200-day EMA in the week gone by, which is a positive sign.

June 26, 2023 / 06:09 IST
Story continues below Advertisement
Stocks
Stocks

Bears retained their reign over Dalal Street for the second straight session with the benchmark indices shedding around half a percent and the broader markets losing more than 1 percent on June 23, tracking downtrend in their global counterparts. Most of key sectors, barring pharma, were under pressure on the last trading day of the week.

The Nifty50 formed bearish candlestick pattern on the daily charts, down 106 points to settle at 18,665 and the BSE Sensex has seen breaching 63,000 mark on the downside, declining 260 points to 62,979.

Story continues below Advertisement

The Bank Nifty has taken a support at 43,500, falling over 100 points to 43,623, while the Nifty IT was also under pressure for yet another session but took support at 28,400-28,300 levels, down more than 250 points to 28,554.

Stocks that were in action on last Friday included DCM Shriram, ICICI Securities, and Natco Pharma. DCM Shriram rallied nearly 6 percent to Rs 917, the highest closing level since November 14 last year, with robust volumes, after consolidating for around a month. The rally helped it get back above 200-day EMA (exponential moving average Rs 864), which is a positive sign.